The EUA for this product is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.įor more information on the EUA authorized uses of the vaccine, refer to the Fact Sheet for Healthcare Providers Administering Vaccine. Certain additional uses are authorized for immunocompromised patients and patients 65 years and older. Moderna recently said it will have a third booster shot in the third quarter of 2021 to help stop the spread of coronavirus variants, according to CNBC. regulators are shortening the time that people who received Modernas COVID-19 vaccine have to wait for a booster to five months rather than six. Moderna COVID-19 Vaccine, Bivalent is authorized for use in individuals 6 years of age and older who were previously unvaccinated or vaccinated with one or more doses of an approved or authorized monovalent COVID-19 vaccine at least 2 months after receipt of any monovalent COVID-19 vaccine. Moderna expects a minimum of 5 billion in revenue from its Covid vaccine, its only available. Moderna COVID-19 Vaccine, Bivalent is authorized for use in individuals 6 months through 5 years of age who were previously unvaccinated or vaccinated with one or two doses of Moderna COVID-19 Vaccine (no longer authorized). Pfizer expects Covid shot revenue to fall to 13.5 billion this year from 37.8 billion in 2022. Moderna COVID-19 Vaccine, Bivalent has not been approved or licensed by the FDA, but has been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |